New Research, Consumer Products Conference Highlight

International Controlled Release Society Symposium In Boston,Massachusetts, USA, June 20-25, 1999 Geneva, Switzerland (PROTEXT) - Can we mimic cancer cells,thereby killing the cancer? Will scientists engineer molecularlife in a test tube without cloning more old Dolly's? Drugdelivery scientists report on these advances at the 26thInternational Symposium on Controlled Release of BioactiveMaterials in Boston, MA, June 20-25, 1999. "This year's International Symposium on Controlled Releaseoffers many outstanding speakers and reports of innovativeclinical and basic research. We will hear interesting reportsfrom our Second Consumer and Diversified Products Conference,"said Vladimir Torchilin, PhD, DSc, professor/chair of theDepartment of Pharmaceutical Sciences at Northeastern University.Dr. Torchilin co-chairs the program with Francesco M. Veronese,PhD, professor in the Department of Pharmaceutical Sciences atItaly's University of Padova. Innovations in research at this year's International Symposiumfeature drug targeting in cancer and cardiovascular disease,novel intracytoplasmic drug delivery, controlled delivery indiagnostics, and drug delivery and biotechnology in the newmillennium. The Second Consumer and Diversified Products Conferencefocuses on functional foods for diabetes, controlled release offlavor, aroma agents, and pesticide applications, said programchair Mary Marshall, P.E., of Southwest Research Institute in SanAntonio, TX. "Our Boston Symposium has all the hallmarks of ascientifically exciting conference. This meeting is setting newrecords, highlighting scientific growth in our Society, expandingthe scope of CRS into gene therapy, biotechnology, and consumerproducts," said Thomas Kissel, PhD, of Philipps- University ofMarburg, Germany, and current president of the Controlled ReleaseSociety. The Controlled Release Society is a international organizationrepresenting a spectrum of scientific fields. Marketed controlledrelease products today include nicotine patches to stop smoking,depot hormone formulations, tablets that bypass the stomach todissolve later. Headquartered in Deerfield, IL, USA, with aEuropean office in Geneva, Switzerland, the Controlled ReleaseSociety serves over 2,400 members from 43 countries. otsOriginal Text Service: Controlled Release Society Internet:http://www.newsaktuell.de Contact: Europe, Daphne Romy, PhD, ofControlled Release Society, in Geneva, Switzerland, (+41) 79 4135684; or United States, Mary Jean Pramik, MS, in San Francisco(USA) 415-456-6766, for the Controlled Release Society

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.

PROTEXT